Search Within

Maura N Dickler

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (61)
  2. Journal Article (43)
  3. Book Section (1)
Groups
  1. Epidemiology and Biostatistics (105)
  2. Survivorship Research (97)
  3. Department of Medicine (96)
  4. Solid Tumor Oncology Division (96)
  5. Breast Medicine Service (95)
  6. Population Sciences Research Program (83)

More Groups

People
  1. Clifford Hudis (64)
  2. Shari Goldfarb (51)
  3. Larry Norton (40)
  4. Sujata Patil (35)
  5. Chau Dang (28)
  6. Diana Lake (24)

More People

Years
  1. 2021 (1)
  2. 2020 (5)
  3. 2019 (2)
  4. 2018 (8)
  5. 2017 (10)
  6. 2016 (5)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. Cancer Research (21)
  3. Breast Cancer Research and Treatment (7)
  4. Clinical Cancer Research (7)
  5. Journal of Sexual Medicine (7)
  6. Fertility and Sterility (5)

More Publications

Publishers
  1. American Association for Cancer Research (30)
  2. American Society of Clinical Oncology (28)
  3. Elsevier Inc. (11)
  4. Springer (9)
  5. Elsevier Science, Inc. (5)
  6. Oxford University Press (5)

More Publishers

Results (105)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of daily PI3K alpha inhibitor BYL719 plus letrozole (L) or exemestane (E) for patients (pts) with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Modi, S.; Datko, F. M.; Moynahan, M. E.; Zamora, S.; D'Andrea, G.; Lake, D.; Goldfarb, S. B.; Patil, S.; Singh, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Monitoring PIK3CA mutant allele fraction (AF) in cell-free DNA (cfDNA) in metastatic breast cancer (MBC) patients treated with PI3K alpha-inhibitor plus letrozole (L) or exemestane (E)
    Meeting Abstract

    Moynahan, M. E.; Sung, P.; Asham, M.; Zamora, S.; Shah, P. D.; Modi, S.; Lake, D.; D'Andrea, G.; Goldfarb, S. B.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Sexual dysfunction in women with lymphoma: Prevalence and etiologies
    Meeting Abstract

    Goldfarb, S. B.; Jackson, T.; Carter, J.; Dickler, M. N.; Noy, A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A Prospective Longitudinal Study of the Impact of Breast Cancer Chemotherapy on Ovarian Reserve: Do Individuals Have Differing Susceptibilities?
    Meeting Abstract

    Oktay, K.; Goldfarb, S.; Bedoschi, G.; Quistorff, J.; Grunblatt, E.; Cigler, T.; Moy, F.; Patil, S.; Goswami, S.; Dickler, M.
    Fertility and Sterility (2014)

    Fulltext@MSK | Save
  • Sexual dysfunction in women with lymphoma: Prevalence and etiologies
    Meeting Abstract

    Goldfarb, S.; Jackson, T.; Carter, J.; Dickler, M.; Noy, A.
    Journal of Sexual Medicine (2014)

    Fulltext@MSK | Save
  • Use of intravaginal 17-ß estradiol to improve sexual function and menopausal symptoms in postmenopausal women with breast cancer on aromatase inhibitors
    Meeting Abstract

    Goldfarb, S. B.; Dickler, M. N.; Dnistrian, A. M.; Patil, S.; Dunn, L.; Chang, K.; Berkowitz, A. P.; Tucker, N.; Carter, J.; Barakat, R. R.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data
    Meeting Abstract

    Iyengar, N. M.; Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • An exploratory analysis of the role of dasatinib in preventing progression of disease in bone in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Morris, P. G.; Lake, D. E.; D'Andrea, G. M.; Dickler, M. N.; Gilewski, T. A.; Dang, C. T.; McArthur, H. L.; Bromberg, J. F.; Goldfarb, S. B.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save